| abstract |
The invention provides a phosphorus-containing compound, which is characterized by being a compound shown in the following structure: the compound is a novel immunocyte migration inhibitor. Has good hydrophilicity, and can be developed into eye drop. Has strong capability of inhibiting the migration of immune cells, and can relieve the symptoms of most patients with dry eye syndrome. |